Transcriptomic Profiling in Low-Risk Thyroid Cancer Induced by Microwave Ablation.

Autor: Li, Huarong¹ (AUTHOR), Liang, Lei¹ (AUTHOR), Li, Jianming^2,3 (AUTHOR)

Publikováno v: International Journal of Endocrinology. 5/15/2024, Vol. 2024, p1-15. 15p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A national survey of physicians regarding active surveillance for low-risk thyroid cancer in Korea.

Autor: Kim MJ; M Kim, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea (the Republic of)., Moon JH; J Moon, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea (the Republic of)., Lee EK; E Lee, Department of Internal Medicine, National Cancer Center, Goyang, Korea (the Republic of)., Song YS; Y Song, Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea (the Republic of)., Jung KY; K Jung, Department of Internal Medicine, Nowon Eulji Medical Center, Seoul, Korea (the Republic of)., Lee JY; J Lee, Department of Radiology, Seoul National University Hospital, Seoul, Korea (the Republic of)., Kim JH; J Kim, Department of Radiology, Seoul National University Hospital, Seoul, Korea (the Republic of)., Lim W; W Lim, Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea (the Republic of)., Kim K; K Kim, Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea (the Republic of)., Park SK; S Park, Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea (the Republic of)., Park YJ; Y Park, Department of Internal Medicine, Seoul National University College of Medicine, Jongno-gu, 03080, Korea (the Republic of).

Publikováno v: European thyroid journal [Eur Thyroid J] 2024 Dec 01. Date of Electronic Publication: 2024 Dec 01.

Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial.

Autor: Leboulleux S; Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy, Paris, France; University Paris-Saclay, Paris, France; Department of Endocrinology and Diabetology, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland. Electronic address: sophie.leboulleux@hug.ch., Bournaud C; Department of Nuclear Medicine, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France., Chougnet CN; Department of Endocrine Oncology, Assistance Publique-Hôpitaux de Paris Hôpital Saint-Louis, Paris, France., Lamartina L; Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy, Paris, France; University Paris-Saclay, Paris, France., Zerdoud S; Department of Nuclear Medicine, Nuclear Oncology, and Thyroid Oncology, IUCT Oncopole Toulouse-Institut Claudius Regaud, Toulouse, France., Do Cao C; Department of Endocrinology, CHRU de Lille-Hôpital Claude Huriez, Lille, France., Catargi B; Department of Endocrinology-Metabolic Diseases, Hôpital Saint-André, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Dygai I; Department of Nuclear Medicine, Centre Georges François Leclerc, Dijon, France., Kelly A; Department of Nuclear Medicine, Centre Jean Perrin, Clermont-Ferrand, France., Barge ML; Department of Nuclear Medicine, Centre Eugene Marquis, Rennes, France., Vera P; Centre Henri Becquerel and Laboratoire QUANTif, Rouen, France., Rusu D; Department of Nuclear Medicine, Centre René Gauducheau, Saint Herblain, France., Schneegans O; Department of Nuclear Medicine, Centre Paul Strauss, Strasbourg, France., Roux J; Department of Nuclear Medicine, CHU Grenoble-Alpes, Grenoble, France., Raymond P; Department of Endocrinology, Centre Hospitalier Régional Universitaire de Nancy, Hôpitaux de Brabois, Vandoeuvre Les Nancy, France., Benisvy D; Department of Nuclear Medicine, Antoine Lacassagne, Nice, France., Eberle MC; Department of Nuclear Medicine, Institut du Cancer de Montpellier, Institut Régional du Cancer Val d'Aurelle, Montpellier, France., Bidault S; Department of Radiology, Gustave Roussy, Paris, France., Nascimento C; Department of Nuclear Medicine, Nuclear Oncology, and Thyroid Oncology, IUCT Oncopole Toulouse-Institut Claudius Regaud, Toulouse, France; Department of Nuclear Medicine, Institut Curie Site Saint-Cloud, Saint-Cloud, France., Bastie D; Department of Nuclear Medicine, CHU Rangueil Toulouse, France., Giraudet AL; Department of Nuclear Medicine, Centre Léon Bérard, Lyon, France., Bardet S; Department of Nuclear Medicine and Thyroid Unit, Centre François Baclesse, Caen, France., Le Moullec N; Department of Endocrinology, CHU Saint Pierre, Saint Pierre, France., Roudaut N; Department of Endocrinology, CHU La Cavale Blanche, Brest, France., Drui D; Department of Endocrinology, L'institut du thorax, CHU de Nantes-Hopital Laennec Saint-Herblain, Nantes, France., Godbert Y; Department of Thyroid Oncology and Nuclear Medicine, Institut Bergonié, Bordeaux, France., Zalzali M; Thyroid Unit, Institut Jean Godinot, Reims, France., Drutel A; Department of Endocrinology, CHU Dupuytren, Limoges, France., Morel O; Department of Nuclear Medicine, Institut de Cancérologie de l'Ouest, Angers, France., Velayoudom FL; Department of Endocrinology, CHU de Guadeloupe, Hôpital Ricou, Les Abymes, France., Al Ghuzlan A; Department of Medical Biology and Pathology, Gustave Roussy, Paris, France; University Paris-Saclay, Paris, France., Schlumberger M; Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy, Paris, France; University Paris-Saclay, Paris, France., Buffet C; Department of Thyroid and Endocrine Tumors, Pitié-Salpêtrière Hospital, Paris, France; Thyroid Tumors Clinical Research Group 16, Sorbonne University, Cancer Institute, Inserm U1146, CNRS UMR 7371, Paris, France., Borget I; Department of Biostatistics and Epidemiology, Gustave Roussy, Paris, France; University Paris-Saclay, Paris, France; Office of Biostatistics and Epidemiology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Inserm, Université Paris-Saclay, CESP U1018, Oncostat, labelled Ligue Contre le Cancer, Villejuif, France.

Publikováno v: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2024 Nov 22. Date of Electronic Publication: 2024 Nov 22.

What do patients want to know about surgery for low-risk thyroid cancer? A qualitative study

Autor: Underwood, Hunter J., Mott, Nicole M., Saucke, Megan C., Roman, Benjamin R., Voils, Corrine I., Pitt, Susan C.

Publikováno v: In Surgery January 2023 173(1):226-231